The PSA has allowed us to detect cancer at an earlier stage, and it has reduced the number of men with widespread metastasis from 40 per cent to less than five per cent. Too much ink and angst have been spilled in debating whether the PSA blood test should be used to screen for prostate cancer. Read the article.
Cochrane reviews are structured, systematic, focused reviews of evidence in the field of medicine that either support or do not support specific forms of diagnosis and management of patients with or suspected of having particular disorders. A newly published Cochrane review by Drost et al. has addressed the topic of “Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer“, and had just been published by the Cochrane Library.
Prostate Cancer Canada is encouraging men to get tested for the potentially deadly disease with a bold campaign that references historical and fictional characters in the form of latex gloves – yes, those donned by doctors for the often dreaded digital rectal exam meant to detect the presence of tumours in the male sex gland. Read the article here.
January 2018 Awareness Night Transperineal Prostate Biopsies: a new paradigm in the diagnosis and monitoring of Prostate Cancer Dr. Stanley Flax MB, BCh, FRCSC Staff Urologist, North York General Hospital, Co-Chair, North York General Hospital’s OR Product Standardization & Evaluation Committee, Director, Gale & Graham Wright Prostate Cancer Centre. Dr. Adam Tunis MD, MSc, FRCPC Clinical Director of Medical Imaging Informatics, Staff Radiologist, North York General Hospital Dept. of Medical Imaging CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 36:22 minutes
A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures – distinguishing cancer from benign conditions, and identifying patients with high-risk disease. Read the article here.
January 2017 Awareness Night The Future of PSA Based Prostate Cancer (PCa) Screening – Screening Smarter and Individualized Risk Assessment Dr. Raj Satkunasivam, MD, MS, FRCSC Urologic Oncologist, Odette Cancer Centre, Sunnybrook Health Sciences Centre Assistant Professor, Division of Urology, Department of Surgery, University of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 40:51 minutes